The hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes

The hits keep coming: Biogen’s Aduhelm marketing, approval under fire in new FTC and SEC probes
fkansteiner
Fri, 02/04/2022 – 10:58